Medidata recommits to Catalyst Clinical Research expanding multi-year partnership
Medidata has recommitted to Catalyst Clinical Research to support its worldwide oncology brand, Catalyst Oncology.
Medidata has recommitted to Catalyst Clinical Research to support its worldwide oncology brand, Catalyst Oncology.
Life sciences investment group and part of global investment firm Carlyle, Abingworth announced last week it had exceeded its $300 million target by $56 million.
With rising healthcare costs and ‘less understood digital therapeutics’ Curavit has launched a health economics and outcomes research (HEOR) practice.